Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system

References

• Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol. 2017;19(suppl_5):v1–v88. doi 10.1093/neuonc/nox15829117289
   PubMed Web of Science ®Google Scholar
• Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2(1):3–14. doi:10.1602/neurorx.2.1.315717053
   PubMedGoogle Scholar
• Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017;9:2. doi:10.3390/pharmaceutics9020012
   Web of Science ®Google Scholar
• Shafei A, El-Bakly W, Sobhy A, et al. A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer. Biomed Pharmacother. 2017;95:1209–1218. doi:10.1016/j.biopha.2017.09.05928931213
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Mochida A, Choyke PL, Kobayashi H. Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer? Bioconjug Chem. 2016;27(10):2225–2238. doi:10.1021/acs.bioconjchem.6b0041727547843
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 2012;64(7):640–665. doi:10.1016/j.addr.2011.11.01022154620
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Cook WG, Fenton ME. Handbook of Pharmaceutical Excipients. 7th ed. London: Pharmaceutical Press; 2012.
   Google Scholar
• Rempel SA, Golembieski WA, Fisher JL, Maile M, Nakeff A. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J Neurooncol. 2001;53(2):149–160. doi:10.1023/A:101220130018811716067
   PubMed Web of Science ®Google Scholar
• Golembieski WA, Ge S, Nelson K, Mikkelsen T, Rempel SA. Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int J Dev Neurosci. 1999;17(5–6):463–472. doi:10.1016/S0736-5748(99)00009-X10571408
   PubMedGoogle Scholar
• Tsou YH, Zhang XQ, Zhu H, Syed S, Xu X. Drug delivery to the brain across the blood-brain barrier using nanomaterials. Small. 2017;13:43. doi:10.1002/smll.201701921
   Web of Science ®Google Scholar
• Quadri SA, Waqas M, Khan I, et al. High-intensity focused ultrasound: past, present, and future in neurosurgery. Neurosurg Focus. 2018;44(2):E16. doi:10.3171/2017.11.FOCUS17610
   PubMed Web of Science ®Google Scholar
• Lipsman N, Meng Y, Bethune AJ, et al. Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound. Nat Commun. 2018;9(1):2336. doi:10.1038/s41467-018-04529-630046032
   PubMedGoogle Scholar
• Choi JJ, Pernot M, Small SA, Konofagou EE. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med Biol. 2007;33(1):95–104. doi:10.1016/j.ultrasmedbio.2006.07.01817189051
   PubMed Web of Science ®Google Scholar
• McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012;72(14):3652–3663. doi:10.1158/0008-5472.CAN-12-012822552291
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang Y, Power C, et al. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model. Proc Natl Acad Sci U S A. 2017;114(48):E10281–E10290. doi:10.1073/pnas.171332811429133392
   PubMedGoogle Scholar
• Wu SK, Chu PC, Chai WY, et al. Characterization of different microbubbles in assisting focused ultrasound-induced blood-brain barrier opening. Sci Rep. 2017;7:46689. doi:10.1038/srep4668928425493
   PubMed Web of Science ®Google Scholar
• Sun T, Sutton JT, Power C, Zhang Y, Miller EL, McDannold NJ. Transcranial cavitation-mediated ultrasound therapy at sub-MHz frequency via temporal interference modulation. Appl Phys Lett. 2017;111(16):163701. doi:10.1063/1.5000896
   Web of Science ®Google Scholar
• Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage. 2005;24(1):12–20. doi:10.1016/j.neuroimage.2004.06.04615588592
   PubMed Web of Science ®Google Scholar
• Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology. 2001;220(3):640–646. doi:10.1148/radiol.220200180411526261
   PubMed Web of Science ®Google Scholar
• Song KH, Fan AC, Hinkle JJ, Newman J, Borden MA, Harvey BK. Microbubble gas volume: a unifying dose parameter in blood-brain barrier opening by focused ultrasound. Theranostics. 2017;7(1):144–152. doi:10.7150/thno.1598728042323
   PubMed Web of Science ®Google Scholar
• Jones RM, Deng L, Leung K, McMahon D, O’Reilly MA, Hynynen K. Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening. Theranostics. 2018;8(11):2909–2926. doi:10.7150/thno.2491129896293
   PubMed Web of Science ®Google Scholar
• Shin J, Kong C, Cho JS, et al. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters. Neurosurg Focus. 2018;44(2):E15. doi:10.3171/2017.11.FOCUS17627
   PubMed Web of Science ®Google Scholar
• Zhao B, Chen Y, Liu J, et al. Blood-brain barrier disruption induced by diagnostic ultrasound combined with microbubbles in mice. Oncotarget. 2018;9(4):4897–4914. doi:10.18632/oncotarget.2352729435150
   PubMedGoogle Scholar
• Yao L, Song Q, Bai W, et al. Facilitated brain delivery of poly (ethylene glycol)-poly (lactic acid) nanoparticles by microbubble-enhanced unfocused ultrasound. Biomate-rials. 2014;35(10):3384–3395. doi:10.1016/j.biomaterials.2014.01.026
   PubMed Web of Science ®Google Scholar
• Bing KF, Howles GP, Qi Y, Palmeri ML, Nightingale KR. Blood-brain barrier (BBB) disruption using a diagnostic ultrasound scanner and definity in mice. Ultrasound Med Biol. 2009;35(8):1298–1308. doi:10.1016/j.ultrasmedbio.2009.03.01219545939
   PubMedGoogle Scholar
• Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 2003;257(1–2):169–180. doi:10.1016/S0378-5173(03)00134-012711172
   PubMed Web of Science ®Google Scholar
• Tinkov S, Coester C, Serba S, et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J Control Release. 2010;148(3):368–372. doi:10.1016/j.jconrel.2010.09.00420868711
   PubMed Web of Science ®Google Scholar
• Hong G, Antaris AL, Dai H. Near-infrared fluorophores for biomedical imaging. Nat Biomed Eng. 2017;1:0010. doi:10.1038/s41551-016-0010
   Web of Science ®Google Scholar
• Lomis N, Westfall S, Farahdel L, Malhotra M, Shum-Tim D, Prakash S. Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization. Nanomater. 2016;6:6. doi:10.3390/nano6060116
   Web of Science ®Google Scholar
• Wei KC, Lin FW, Huang CY, et al. 1,3-Bis(2-chloroethyl)-1-nitrosourea-loaded bovine serum albumin nanoparticles with dual magnetic resonance-fluorescence imaging for tracking of chemotherapeutic agents. Int J Nanomedicine. 2016;11:4065–4075. doi:10.2147/IJN.S11358927601895
   PubMed Web of Science ®Google Scholar